# Neko Health Funding: How Much It Raised, Its Valuation & Investors

> Neko Health raised $700 million in a Series C round at a $7 billion valuation in July 2026, led by Lightspeed Venture Partners and O.G. Venture Partners. Here's the full breakdown of the round and backers.

_[Wortins Blog](https://www.wortins.com/blog) · Published Thursday, July 23, 2026_

**Neko Health raised $700 million in a Series C round at a $7 billion valuation**, announced on July 15, 2026 and led by **Lightspeed Venture Partners and O.G. Venture Partners**. It's a roughly 4x jump from the company's valuation just 18 months earlier, as investors keep piling into AI-driven preventive health.

Here's the full breakdown of the raise, who backed it, and what it means for the diagnostics market.

## What is Neko Health?

Neko Health runs a **preventive healthcare platform** built around AI-powered full-body scans that check for early signs of disease through skin analysis, metabolic markers and cardiovascular risk assessment. The company was founded in **2023** by **Daniel Ek**, the co-founder and CEO of Spotify, marking a notable move from consumer streaming into consumer health diagnostics.

In plain terms: instead of waiting for symptoms to send someone to a doctor, Neko's scanning clinics run a battery of AI-assisted checks in a single visit, aiming to catch disease markers before they become serious. The company currently operates through **healthcare networks in Northern Europe**, with a **U.S. expansion** now planned.

## The raise: $700M Series C

The headline numbers:

- **Amount:** $700 million
- **Round:** Series C
- **Valuation:** $7 billion
- **Announced:** July 15, 2026
- **Lead investors:** Lightspeed Venture Partners, O.G. Venture Partners

Neko Health's valuation trajectory has been steep from the start. The company raised a **$40 million Series A in 2024**, then a **$150 million Series B at a $1.7 billion valuation in early 2025**. Jumping to a **$7 billion valuation** roughly 18 months later is about a **4x increase**, a pace that puts Neko Health among the faster-appreciating consumer health startups of the AI era.

## Who invested in Neko Health?

The Series C was led by **Lightspeed Venture Partners** and **O.G. Venture Partners**, with additional participation from:

- **Atomico**
- **General Catalyst**
- **Lakestar**

That mix of U.S. growth investors (Lightspeed) alongside established European venture firms (Atomico, Lakestar) reflects Neko Health's dual footprint — a European clinical base with ambitions to scale into the U.S. market.

## What Neko Health will do with the money

Neko Health says the funding will go toward **expanding from its European base into the U.S. market**, including establishing new clinics and running the **clinical validation** work needed to operate in a more heavily regulated healthcare environment. Entering the U.S. market is a materially different undertaking than scaling in Northern Europe — it requires new regulatory approvals, new clinical partnerships, and capital-intensive physical clinic buildouts, all of which this round is meant to fund.

## Why it matters

1. **AI-driven diagnostics are proving to be a defensible consumer business.** A 4x valuation increase in 18 months signals that investors see Neko Health's combination of AI analysis and physical scanning clinics as a durable model, not a novelty — a pattern echoed across the [biggest AI funding rounds of 2026](/blog/biggest-ai-funding-rounds-2026), where health and diagnostics startups are commanding premium valuations alongside infrastructure plays.
2. **Preventive care is becoming an AI investment category of its own.** As healthcare systems shift toward early detection rather than treating disease after the fact, Neko Health's raise suggests investors are willing to fund the capital-intensive physical infrastructure — clinics and scanning hardware — that AI-native health diagnostics require.

For anyone tracking where consumer-facing AI applications are attracting serious capital in 2026, Neko Health's raise shows that preventive diagnostics has become one of the categories investors are willing to back at scale.

Source: [TechCrunch — Daniel Ek's Neko Health raises $700M](https://techcrunch.com/2026/07/15/daniel-eks-body-scanning-startup-neko-health-raises-another-700m)

---

*Following AI funding? Wortins tracks the biggest raises, valuations, and acquisitions daily in the [AI Funding Tracker](/funding).*

## Frequently asked questions

### How much did Neko Health raise?

Neko Health raised $700 million in a Series C round announced on July 15, 2026.

### What is Neko Health's valuation?

The Series C valued Neko Health at $7 billion, up from $1.7 billion at its Series B in early 2025 — roughly a 4x increase in about 18 months.

### Who invested in Neko Health?

The round was led by Lightspeed Venture Partners and O.G. Venture Partners, with Atomico, General Catalyst and Lakestar also participating.

### What does Neko Health do?

Neko Health operates a preventive healthcare platform offering AI-powered full-body scans that check skin, metabolic markers and cardiovascular risk to detect early signs of disease. It was founded by Spotify co-founder Daniel Ek.

---

_Curated and written by [Wortins](https://www.wortins.com) — The daily AI briefing. Every story links to its original source; the "Wortins read" on each is our own original analysis. [About Wortins & our editorial approach](https://www.wortins.com/about)._